ArticleBMC cancer2025
Development and validation of a CT-radiomics model for the diagnosis of lung cancer associated with cystic airspaces: a multicenter study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancers associated with cystic airspaces (LCCA) are often subject to clinical misdiagnosis. The aim of this study was to establish a diagnostic model that integrates clinical characteristics and preoperative CT radiomic features, thereby providing a novel non-invasive tool for the diagnosis of LCCA.
methodsPatients with lung cystic lesions from two hospitals were retrospectively reviewed. One hospital's cohort was used for training and internal validation, the other for external validation. Radiomics texture features were extracted from arterial phase images of preoperative contrast-enhanced CT. Clinical, radiomics, and hybrid models were developed by combining clinical and radiological features to differentiate benign from malignant lesions, with model performance evaluated and compared.
resultsA total of 355 patients (median age 59 years [IQR: 52-66]; 57.7% male) were enrolled, including 274 with LCCA and 81 with benign lesions. Age, ground-glass opacity, and Rad-score were independent predictors of lesion type. The hybrid model outperformed other models, with AUCs of 0.87 (95% CI: 0.80-0.94), 0.85 (95% CI: 0.73-0.98), and 0.86 (95% CI: 0.78-0.94) in the training, internal test, and external test sets, respectively. The model showed excellent calibration and significant clinical utility based on decision curve analysis.
conclusionWe have developed and validated a hybrid model that can offer valuable assistance in preoperatively distinguishing between LCCA and benign cystic lesions, thereby facilitating clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.